Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Peter Spurgeon a Health Services Management Centre, School of
Public Policy, University of Birmingham, Park House, Birmingham
B15 2RT, b CRC Institute for Cancer Studies, Medical
School, University of Birmingham, Birmingham B15 2TJ
Correspondence
to: P Spurgeon p.spurgeon@bham.ac.uk
| The first 150 words of the full text of this article appear below. |
Britain fares rather badly in international comparisons of cancer patients' survival rates. Relative survival rates in England and Wales1 are generally lower than in Europe,2 which in turn are lower than rates in the United States.3 The differences between England and Wales and the rest of Western Europe in survival rates for colon cancer and female breast cancer arise primarily in the first six months after diagnosis, suggesting that these differences may relate to later presentation or delays in treatment for British patients.
Given this background, the government has pledged to "end waiting
times for cancer surgery, thereby helping thousands of women waiting
for breast cancer treatment." The assumption is that reduced waiting
times will lead to more rapid diagnosis, earlier instigation of care,
and reduced psychological morbidity. Indeed, the NHS has been asked to
set a target of two weeks from referral by a general practitioner to
first hospital
Read all Rapid Responses